questionsmedicales.fr
Composés chimiques organiques
Composés du soufre
Acides du soufre
Acides sulfoniques
Acides arènesulfoniques
Arènesulfonates
Benzènesulfonates
Benzènesulfonates : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Benzènesulfonates : Questions médicales les plus fréquentes",
"headline": "Benzènesulfonates : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Benzènesulfonates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-26",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Benzènesulfonates"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Arènesulfonates",
"url": "https://questionsmedicales.fr/mesh/D001190",
"about": {
"@type": "MedicalCondition",
"name": "Arènesulfonates",
"code": {
"@type": "MedicalCode",
"code": "D001190",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.645.600.080.050"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dobésilate de calcium",
"alternateName": "Calcium Dobesilate",
"url": "https://questionsmedicales.fr/mesh/D002123",
"about": {
"@type": "MedicalCondition",
"name": "Dobésilate de calcium",
"code": {
"@type": "MedicalCode",
"code": "D002123",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.645.600.080.050.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "4-Chloromercurio-benzènesulfonate",
"alternateName": "4-Chloromercuribenzenesulfonate",
"url": "https://questionsmedicales.fr/mesh/D002731",
"about": {
"@type": "MedicalCondition",
"name": "4-Chloromercurio-benzènesulfonate",
"code": {
"@type": "MedicalCode",
"code": "D002731",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.645.600.080.050.100.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"alternateName": "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt",
"url": "https://questionsmedicales.fr/mesh/D014013",
"about": {
"@type": "MedicalCondition",
"name": "1,2-Dihydroxy-benzène-3,5-disulfonate de disodium",
"code": {
"@type": "MedicalCode",
"code": "D014013",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.645.600.080.050.100.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Étamsylate",
"alternateName": "Ethamsylate",
"url": "https://questionsmedicales.fr/mesh/D004979",
"about": {
"@type": "MedicalCondition",
"name": "Étamsylate",
"code": {
"@type": "MedicalCode",
"code": "D004979",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.645.600.080.050.100.300"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Benzènesulfonates",
"alternateName": "Benzenesulfonates",
"code": {
"@type": "MedicalCode",
"code": "D001557",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Atziri Corin Chavez Alvarez",
"url": "https://questionsmedicales.fr/author/Atziri%20Corin%20Chavez%20Alvarez",
"affiliation": {
"@type": "Organization",
"name": "Centre de recherche du CHU de Québec-Université Laval, Axe oncologie, Québec, QC, Canada; Faculté de pharmacie, Université Laval, Pavillon Ferdinand-Vandry, 1050 avenue de la Médecine, Québec QC G1V 0A6, Canada; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, 2725 chemin Ste-Foy, Québec QC G1V 4G5, Canada."
}
},
{
"@type": "Person",
"name": "Sébastien Fortin",
"url": "https://questionsmedicales.fr/author/S%C3%A9bastien%20Fortin",
"affiliation": {
"@type": "Organization",
"name": "Centre de recherche du CHU de Québec-Université Laval, Axe oncologie, Québec, QC, Canada; Faculté de pharmacie, Université Laval, Pavillon Ferdinand-Vandry, 1050 avenue de la Médecine, Québec QC G1V 0A6, Canada. Electronic address: sebastien.fortin@pha.ulaval.ca."
}
},
{
"@type": "Person",
"name": "Chahrazed Bouzriba",
"url": "https://questionsmedicales.fr/author/Chahrazed%20Bouzriba",
"affiliation": {
"@type": "Organization",
"name": "Centre de recherche du CHU de Québec-Université Laval, Axe oncologie, Québec, QC, Canada; Faculté de pharmacie, Université Laval, Pavillon Ferdinand-Vandry, 1050 avenue de la Médecine, Québec QC G1V 0A6, Canada; These authors contributed equally to this work. Electronic address: chahrazed.bouzriba.1@ulaval.ca."
}
},
{
"@type": "Person",
"name": "Mathieu Gagné-Boulet",
"url": "https://questionsmedicales.fr/author/Mathieu%20Gagn%C3%A9-Boulet",
"affiliation": {
"@type": "Organization",
"name": "Centre de recherche du CHU de Québec-Université Laval, Axe oncologie, Québec, QC, Canada; Faculté de pharmacie, Université Laval, Pavillon Ferdinand-Vandry, 1050 avenue de la Médecine, Québec QC G1V 0A6, Canada; These authors contributed equally to this work."
}
},
{
"@type": "Person",
"name": "Vincent Ouellette",
"url": "https://questionsmedicales.fr/author/Vincent%20Ouellette",
"affiliation": {
"@type": "Organization",
"name": "Centre de recherche du CHU de Québec-Université Laval, Axe oncologie, Québec, QC, Canada; Faculté de pharmacie, Université Laval, Pavillon Ferdinand-Vandry, 1050 avenue de la Médecine, Québec QC G1V 0A6, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.",
"datePublished": "2023-07-27",
"url": "https://questionsmedicales.fr/article/37516418",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.actbio.2023.07.042"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pro-Apoptotic Activity and Cell Cycle Arrest of",
"datePublished": "2023-05-26",
"url": "https://questionsmedicales.fr/article/37298837",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules28114361"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cell Cycle Regulation by Integrin-Mediated Adhesion.",
"datePublished": "2022-08-14",
"url": "https://questionsmedicales.fr/article/36010598",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells11162521"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis.",
"datePublished": "2023-07-13",
"url": "https://questionsmedicales.fr/article/37451663",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cbi.2023.110634"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mitochondrial Metabolism in X-Irradiated Cells Undergoing Irreversible Cell-Cycle Arrest.",
"datePublished": "2023-01-17",
"url": "https://questionsmedicales.fr/article/36768155",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24031833"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés du soufre",
"item": "https://questionsmedicales.fr/mesh/D013457"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides du soufre",
"item": "https://questionsmedicales.fr/mesh/D013456"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acides sulfoniques",
"item": "https://questionsmedicales.fr/mesh/D013451"
},
{
"@type": "ListItem",
"position": 6,
"name": "Acides arènesulfoniques",
"item": "https://questionsmedicales.fr/mesh/D017739"
},
{
"@type": "ListItem",
"position": 7,
"name": "Arènesulfonates",
"item": "https://questionsmedicales.fr/mesh/D001190"
},
{
"@type": "ListItem",
"position": 8,
"name": "Benzènesulfonates",
"item": "https://questionsmedicales.fr/mesh/D001557"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Benzènesulfonates - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Benzènesulfonates",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Benzènesulfonates",
"description": "Comment diagnostiquer une exposition aux benzènesulfonates ?\nQuels tests sont utilisés pour détecter les benzènesulfonates ?\nQuels symptômes indiquent une intoxication aux benzènesulfonates ?\nLes benzènesulfonates sont-ils détectables par imagerie ?\nY a-t-il des marqueurs biologiques pour les benzènesulfonates ?",
"url": "https://questionsmedicales.fr/mesh/D001557?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Benzènesulfonates",
"description": "Quels sont les symptômes d'une exposition aiguë ?\nLes benzènesulfonates provoquent-ils des allergies ?\nQuels effets à long terme peuvent causer les benzènesulfonates ?\nLes benzènesulfonates affectent-ils le système nerveux ?\nPeut-on ressentir des symptômes digestifs ?",
"url": "https://questionsmedicales.fr/mesh/D001557?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Benzènesulfonates",
"description": "Comment prévenir l'exposition aux benzènesulfonates ?\nDes formations sont-elles nécessaires pour manipuler ces composés ?\nQuels équipements de protection sont recommandés ?\nLes fuites de benzènesulfonates doivent-elles être signalées ?\nComment stocker les benzènesulfonates en toute sécurité ?",
"url": "https://questionsmedicales.fr/mesh/D001557?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Benzènesulfonates",
"description": "Quel traitement pour une intoxication aux benzènesulfonates ?\nDes antidotes existent-ils pour les benzènesulfonates ?\nComment traiter les irritations cutanées causées par ces composés ?\nLes soins d'urgence sont-ils nécessaires ?\nQuels médicaments peuvent aider en cas d'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D001557?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Benzènesulfonates",
"description": "Quelles complications peuvent survenir après exposition ?\nLes benzènesulfonates peuvent-ils causer des cancers ?\nY a-t-il des effets sur la reproduction ?\nLes benzènesulfonates affectent-ils le développement des enfants ?\nPeut-on développer une sensibilisation aux benzènesulfonates ?",
"url": "https://questionsmedicales.fr/mesh/D001557?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Benzènesulfonates",
"description": "Qui est le plus à risque d'exposition ?\nLes enfants sont-ils plus vulnérables ?\nLes personnes allergiques sont-elles plus à risque ?\nL'environnement peut-il influencer le risque d'exposition ?\nLes habitudes de travail influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D001557?mesh_terms=Cell+Cycle+Checkpoints&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une exposition aux benzènesulfonates ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les benzènesulfonates ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication aux benzènesulfonates ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Les benzènesulfonates sont-ils détectables par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'imagerie ne permet pas de détecter les benzènesulfonates, seuls des tests biologiques le peuvent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour les benzènesulfonates ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des métabolites spécifiques peuvent être mesurés dans les fluides corporels."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des nausées et des irritations des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les benzènesulfonates provoquent-ils des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent provoquer des réactions allergiques cutanées chez certaines personnes."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme peuvent causer les benzènesulfonates ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des troubles respiratoires et des problèmes dermatologiques."
}
},
{
"@type": "Question",
"name": "Les benzènesulfonates affectent-ils le système nerveux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition peut causer des troubles neurologiques comme des maux de tête persistants."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des symptômes digestifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des nausées et des douleurs abdominales peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux benzènesulfonates ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Des formations sont-elles nécessaires pour manipuler ces composés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des formations sur la sécurité chimique sont essentielles pour les travailleurs."
}
},
{
"@type": "Question",
"name": "Quels équipements de protection sont recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des gants, des masques et des lunettes de protection sont recommandés."
}
},
{
"@type": "Question",
"name": "Les fuites de benzènesulfonates doivent-elles être signalées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, toute fuite doit être signalée immédiatement aux autorités compétentes."
}
},
{
"@type": "Question",
"name": "Comment stocker les benzènesulfonates en toute sécurité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les stocker dans des contenants hermétiques et dans un endroit bien ventilé."
}
},
{
"@type": "Question",
"name": "Quel traitement pour une intoxication aux benzènesulfonates ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à éliminer l'exposition et à gérer les symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les benzènesulfonates ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par ces composés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des crèmes apaisantes et éviter tout contact avec le produit irritant."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en cas d'exposition sévère, des soins d'urgence peuvent être requis."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent aider en cas d'exposition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques peuvent être prescrits pour les réactions allergiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications respiratoires et dermatologiques peuvent se développer après exposition."
}
},
{
"@type": "Question",
"name": "Les benzènesulfonates peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel avec certains types de cancers, mais des recherches sont nécessaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets sur la reproduction ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée pourrait affecter la fertilité, mais des études supplémentaires sont requises."
}
},
{
"@type": "Question",
"name": "Les benzènesulfonates affectent-ils le développement des enfants ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches indiquent des risques potentiels pour le développement, nécessitant une attention particulière."
}
},
{
"@type": "Question",
"name": "Peut-on développer une sensibilisation aux benzènesulfonates ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une sensibilisation peut se développer, entraînant des réactions allergiques plus graves."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et ceux manipulant des produits contenant ces composés."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques des benzènesulfonates."
}
},
{
"@type": "Question",
"name": "Les personnes allergiques sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents d'allergies peuvent être plus susceptibles de réagir."
}
},
{
"@type": "Question",
"name": "L'environnement peut-il influencer le risque d'exposition ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre près d'industries utilisant ces composés augmente le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Les habitudes de travail influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des pratiques de travail non sécurisées augmentent le risque d'exposition aux benzènesulfonates."
}
}
]
}
]
}
Radiotherapy is a mainstream modality for breast cancer treatment that employs ionizing radiation (IR) to damage tumor cell DNA and elevate ROS stress, which demonstrates multiple clinically-favorable...
Cancer is a disease with the highest mortality and morbidity rate worldwide. First-line drugs induce several side effects that drastically reduce the quality of life of people with this disease. Findi...
Cell cycle and cell adhesion are two interdependent cellular processes regulating each other, reciprocally, in every cell cycle phase. The cell adhesion to the extracellular matrix (ECM) via integrin ...
Despite the existence of extensive clinical research and novel therapeutic treatments, cancer remains undefeated and the significant cause of death worldwide. Cancer is a disease in which growth of ce...
Irreversible cell-cycle-arrested cells not undergoing cell divisions have been thought to be metabolically less active because of the unnecessary consumption of energy for cell division. On the other ...
Fourteen new thienylnicotinamidines and their analogs 5a-5k, 12, 13a, and 13b were prepared and their antiproliferative potential was evaluated against the growth of 60 cancer cell lines. The tested c...
Over the history of the coevolution of Host viral interaction, viruses have customized the host cellular machinery into their use for viral genome replication, causing effective infection and ultimate...
Apoptotic agents from natural products like phenolic compounds can be used effectively in the treatment of cancer. Chlorogenic acid (CGA) is one of the phenolic compounds in medicinal plants with anti...
HT-29 and HEK-293 cells were cultured after MTT assay for 24 h with CGA 100 µM, and without CGA. Then, flow cytometry assays and the expression of apoptosis-related genes including caspase 3 and 9, Bc...
The cell viability of all two-cell lines decreased in a dose-dependent manner. Moreover, CGA induces cell cycle arrest in HT-29 cells by increasing the expression of P21 and P53. It also induces apopt...
Considering the cytotoxicity and cell cycle arrest and induction of apoptosis in the colon cancer cell line by CGA, it can be concluded that CGA is a suitable option for the treatment of colon cancer....
RTA dh404 is a novel synthetic oleanolic acid derivative that has been reported to possess anti-allergic, neuroprotective, antioxidative, and anti-inflammatory properties, and exerts therapeutic effec...
Oral squamous cell carcinoma (OSCC) exhibits the highest lethality among head and neck cancers. Treatment for OSCC is limited due to diverse side effects. Quercetin is a natural flavonoid compound fou...
For our study, two different types of OSCC cells were used. YD10B cells are tongue SCC cells with the p53 mutation and YD38 cells are lower gingiva SCC cells without the p53 mutation, respectively. Th...
Our results showed that quercetin decreased cell viability and induced G1 cell cycle arrest in YD10B and YD38 OSCC cells. Moreover, quercetin remarkably decreased the expression of cell cycle upregula...
In conclusion, this study demonstrates that quercetin shows different anti-cancer responses in OSCC with and without p53 mutation, respectively. Despite different p53 status in OSCC cells, quercetin l...